Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Estimating bladder cancer risk with novel AI models

Principal Investigator
Name
Nicolas Martelin
Degrees
M.B.A., Ph.D.
Institution
Prostperia SAS
Position Title
Managing Director
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-1382
Initial CDAS Request Approval
Nov 13, 2023
Title
Estimating bladder cancer risk with novel AI models
Summary
Bladder cancer stands as a prevalent and potentially fatal disease, demanding efficient and precise screening approaches for early identification and treatment. This Artificial Intelligence (AI) project is focused on enhancing the detection of sub-groups of women and men at a higher risk of bladder cancer through the implementation of machine learning algorithms and data analytics.
Aims

- Early Detection: Develop an AI-powered system to find groups of women and men at a higher risk of bladder cancer.
- Reduction of False Positives: Minimize false positives in cancer screening results to avoid unnecessary anxiety and additional confirmatory tests.
- Cost-Efficiency: Enhance cost-effectiveness in healthcare by reducing unnecessary tests and focusing resources on cases with a higher probability of malignancy.

Collaborators

Nicolas Martelin
Benjamin Chen